Search - tctmd.com

Displaying 641 - 660 of 2033

Sort: Relevancy | Date

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Industry News

Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories

June 07, 2019

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Industry News

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

June 04, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Daily News

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Todd Neale

May 21, 2019

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Todd Neale

May 15, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

May 07, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

News Industry News

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

May 02, 2019

News Industry News

Medtronic Receives FDA Approval for CareLink SmartSync Device Manager

May 02, 2019

Advertisement

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

Medtronic Receives FDA Approval for CareLink SmartSync Device Manager

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content